Granite Point Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$2.73M Buy
22,778
+8,580
+60% +$993K 0.41% 15
2015
Q3
$1.54M Sell
14,198
-778
-5% -$96.5K 1.05% 19
2015
Q2
$1.73M Sell
14,976
-5,024
-25% -$574K 0.5% 28
2015
Q1
$2.31M Buy
20,000
+4,000
+25% +$478K 0.84% 21
2014
Q4
$1.79M Buy
16,000
+4,000
+33% +$422K 0.84% 23
2014
Q3
$1.14M Hold
12,000
0.57% 35
2014
Q2
$1.03M Buy
12,000
+3,600
+43% +$274K 0.71% 31
2014
Q1
$586K Sell
8,400
-11,600
-58% -$919K 0.42% 73
2013
Q4
$1.69M Buy
+20,000
New +$1.58M 0.28% 36

Other funds holding CELG

Granite Point Capital Management's CELG Position: Q4 2015 in Review

Granite Point Capital Management increased its Celgene Corp (CELG) stake by 60% in Q4 2015, buying an estimated $993K and bringing the position to 22,778 shares worth $2.73M. The position accounts for 0.41% of the portfolio, ranked #15.

Granite Point Capital Management first reported a position in CELG in Q4 2013 and has held it in 9 quarters since. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • Granite Point Capital Management held 22,778 shares of Celgene Corp worth $2.73M as of Q4 2015.
  • Granite Point Capital Management bought 8,580 Celgene Corp shares in Q4 2015, an estimated $993K.
  • Celgene Corp made up 0.41% of Granite Point Capital Management's portfolio in Q4 2015, its #15 holding.
  • Granite Point Capital Management first reported a position in Celgene Corp in Q4 2013 and has held it in 9 quarters since.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Granite Point Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.